Integra LifeSciences (IART) Tops Q2 EPS by 14c

Integra LifeSciences (NASDAQ: IART) reported Q2 EPS of $0.71, $0.14 better than the analyst estimate of $0.57. Revenue for the quarter came in at $381.3 million versus the consensus estimate of $374.07 million.

For earnings history and earnings-related data on Integra LifeSciences (IART) click here.

You May Also Be Interested In

• Key things to know ahead of SK Hynix’s blockbuster US listing
• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• SanDisk surges as Meta memo confirms multi-year flash storage deal